CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Hepatitis B surface antigen levels at 6 months after treatment can predict the efficacy of lamivudine-adefovir combination therapy in patients with lamivudine-resistant chronic hepatitis B

Jeong Han Kim, Hee Won Moon, Soon Young Ko, Won Hyeok Choe, So Young Kwon

Clin Mol Hepatol. 2014;20(3):274-282. Published online 2014 September 25 DOI: https://doi.org/10.3350/cmh.2014.20.3.274

Hepatitis B surface antigen levels at 6 months after treatment can predict the efficacy of lamivudine-adefovir combination therapy in patients with lamivudine-resistant chronic hepatitis B

Jeong Han Kim, Hee Won Moon, Soon Young Ko, Won Hyeok Choe, So Young Kwon

Clinical and Molecular Hepatology. 2014;20(3):274

Link1 Link2 Link3

504 Twenty-four months combination therapy with adefovir dipivoxil and lamivudine in lamivudine resistant patients with HBeAg-negative chronic hepatitis B

Journal of Hepatology. 2005;42:182

Link1 Link2

Adefovir plus lamivudine combination therapy in lamivudine-resistant chronic hepatitis B

So Young Kwon

The Korean Journal of Hepatology. 2008;14(2):235

Link1 Link2 Link3

Failure of adefovir 20 mg to improve suboptimal response in lamivudine-resistant hepatitis B patients treated with adefovir 10 mg and lamivudine

M. Viganò, P. Lampertico, F. Facchetti, G. Lunghi, M. Colombo

Journal of Viral Hepatitis. 2008;15(12):922-924

Link1 Link2

101 High levels of HBsAg clearance after adefovir dipivoxil treatment in patients with chronic hepatitis B lamivudine-resistant post liver transplant

Journal of Hepatology. 2005;42:44

Link1 Link2

Tenofovir plus lamivudine as rescue therapy for adefovir-resistant chronic hepatitis B in hepatitis B e antigen-positive patients with liver cirrhosis

Won Hyeok Choe, So Young Kwon, Byung Kook Kim, Soon Young Ko, Jong Eun Yeon, Kwan Soo Byun, Gyun-Hwan Kim, Chang Hong Lee

Liver International. 2008;28(6):814-820

Link1 Link2

Long-term efficacy of entecavir therapy in chronic hepatitis B patients with antiviral resistance to lamivudine and adefovir

M. S. Kwak, J. W. Choi, J. S. Lee, K. A. Kim, J. H. Suh, Y. S. Cho, S. Y. Won, B. K. Park, C. K. Lee

Journal of Viral Hepatitis. 2011;18(10):e432-e438

Link1 Link2

The Feasibility of Discontinuing Lamivudine in Lamivudine-Resistant Chronic Hepatitis B Patients on Lamivudine and Adefovir Combination Therapy

Seong Min Chung, Young-Sang Byoun, Hee-Sup Kim, Eun Sun Jang, Jin-Wook Kim, Sook-Hyang Jeong

Intervirology. 2014;57(6):337-343

Link1 Link2

501 Adefovir dipivoxil alone or in combination with lamivudine in HBeAg negative patients with lamivudine resistant chronic hepatitis B: A prospective, randomized study

Journal of Hepatology. 2005;42:181

Link1 Link2

M1920 The Efficacy of Combination Therapy with Adefovir and Lamivudine in Patients with Chronic Hepatitis B

Jose Giron, Nikolaos T. Pyrsopoulos

Gastroenterology. 2008;134(4):A-811

Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Clin Mol Hepatol has participated in CrossRef Text and Data Mining service since March 1, 2015.